CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Commercial Officer acquired 200,000 shares (grant or award)
- 4 Planned sale Director sold 2,000 shares at $1.91 ($3,820)
- 4 Planned sale Director sold 2,000 shares at $2.69 ($5,380)
- 4 Open-market sale Chief Executive Officer sold 1,880 shares at $2.80 ($5,264)
- 4 Open-market sale Chief Commercial Officer sold 791 shares at $16.53 ($13,075)
- 4/A Open-market sale Chief Commercial Officer sold 1,758 shares at an average $17.04 ($29,951)
- 4 Planned sale SVP, China Operations sold 12,500 shares at an average $17.19 ($214,925)
- 4 Planned sale Director sold 3,944 shares at an average $17.17 ($67,717)
- 4 Planned sale Director sold 4,733 shares at an average $17.19 ($81,367)
- 4 Planned sale Director sold 8,520 shares at an average $17.20 ($146,571)
- 4 Planned sale Director sold 8,520 shares at an average $17.44 ($148,591)
- 4 Grant or award Director acquired 8,289 shares (grant or award)
- 4 Planned sale Director sold 7,889 shares at an average $17.19 ($135,622)
- 4 Planned sale Director sold 7,000 shares at an average $17.46 ($122,185)
- 4 Planned sale Director sold 7,100 shares at $18.03 ($127,987)
- 4 Open-market sale Chief Commercial Officer sold 1,758 shares at an average $17.04 ($29,951)
- 4 Open-market sale Chief Financial Officer sold 1,785 shares at an average $16.99 ($30,320)
- 4 Open-market sale SVP, China Operations sold 3,633 shares at an average $17.04 ($61,894)
- 4 Open-market sale EVP, Chief Medical Officer sold 2,042 shares at $17.04 ($34,792)
Page 5 of 38 · 760 filings